Published June 29, 2022 | Version v1

''Eight-year efficacy update of the HOBOE randomized phase 3 trial in premenopausal patients with hormone-receptor positive early breast cancer comparing triptorelin plus either Tamoxifen or Letrozole or Zoledronic acid + Letrozole'' - dataset

Authors/Creators

  • 1. NCI Naples

Description

Dataset for analysis of the manuscript ''Eight-year efficacy update of the HOBOE randomized phase 3 trial in premenopausal patients with hormone-receptor positive early breast cancer comparing triptorelin plus either Tamoxifen or Letrozole or Zoledronic acid + Letrozole''

Files

Files (54.4 kB)

Name Size
md5:75ef884ce8a340ecd4468e65c7d0705d
54.4 kB Download